Which of the following is not a first line therapy in ITP?

c. Rituximab

Rituximab is not considered a first-line therapy for immune thrombocytopenic purpura (ITP). First-line treatments typically include IVIg, Anti-D, and steroids. Rituximab is usually reserved for cases that do not respond to these initial therapies.